CRIS
Permanent URI for this communityhttps://investigadores.udd.cl/handle/123456789/1
Browse
2 results
Search Results
Now showing 1 - 2 of 2
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, A Tetrameric Peptide Derived from Bovine Lactoferricin Exhibits Specific Cytotoxic Effects against Oral Squamous-Cell Carcinoma Cell Lines(2015) ;Víctor A. Solarte ;Jaiver E. Rosas ;Zuly J. Rivera ;Martha L. Arango-RodríguezJavier E. García<jats:p>Several short linear peptides derived from cyclic bovine lactoferricin were synthesized and tested for their cytotoxic effect against the oral cavity squamous-cell carcinoma (OSCC) cell lines CAL27 and SCC15. As a control, an immortalized and nontumorigenic cell line, Het-1A, was used. Linear peptides based on the RRWQWR core sequence showed a moderate cytotoxic effect and specificity towards tumorigenic cells. A tetrameric peptide, LfcinB(20–25)<jats:sub>4</jats:sub>, containing the RRWQWR motif, exhibited greater cytotoxic activity (>90%) in both OSCC cell lines compared to the linear lactoferricin peptide or the lactoferrin protein. Additionally, this tetrameric peptide showed the highest specificity towards tumorigenic cells among the tested peptides. Interestingly, this effect was very fast, with cell shrinkage, severe damage to cell membrane permeability, and lysis within one hour of treatment. Our results are consistent with a necrotic effect rather than an apoptotic one and suggest that this tetrameric peptide could be considered as a new candidate for the therapeutic treatment of OSCC.</jats:p>Scopus© Citations 33 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Suicide HSVtk Gene Delivery by Neurotensin-Polyplex Nanoparticles via the Bloodstream and GCV Treatment Specifically Inhibit the Growth of Human MDA-MB-231 Triple Negative Breast Cancer Tumors Xenografted in Athymic Mice(2014) ;Rosa A. Castillo-Rodríguez ;Martha L. Arango-Rodríguez ;Lourdes Escobedo ;Daniel Hernandez-BaltazarAnne Gompel9Scopus© Citations 26